| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 15,300 | $30 | $520.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 21,000 | $10 | $231K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 45,800 | $1 | $183.2K |
| J3262 | Injection, tocilizumab, 1 mg | 23,870 | $10 | $119.4K |
| J0897 | Injection, denosumab, 1 mg | 6,360 | $20 | $114.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,210 | $90 | $111.7K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 9,240 | $10 | $73.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,410 | $30 | $62.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 340 | $50 | $17.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 110 | $130 | $13.5K |